Intravesical epirubicin in the prophylaxis of superficial bladder cancer

International Urology and Nephrology

Volumn 28, Issue 2, 1996, Pages 201-206

  Sengor F ^a   Beysel, M ^a   Erdooan K ^a   Erol, A ^a   Tuzluoolu D ^a  

^a HAYDARPASA NUMUNE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN;

ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; PROPHYLAXIS; REGIONAL PERFUSION; TRANSURETHRAL RESECTION;

EID: 0029947882     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02550861     Document Type: Article

References (14)

1. Silverberg, E., Boring, C. C., Squires, T. S..: Cancer statistics, 1990. CA. 40, 9 (1990).
2. Fitzpatrick, J. D., Reda, M..: Bladder carcinoma in patients 40 years old or less. J. Urol., 135, 53(1986).
3. Fitzpatrick, J. M., West, A. B., Butiler, M. R., Lane, V., O'Flynn, J. D..: Superficial bladder tumors (stage pTa, grades 1 and 2).: The importance of recurrence pattern following initial resection. J. Urol, 135. 920 (1986).
4. Van Der Meijden, A. P. M., Kurth, K., Oosterlinck, W., Debruyne, F. M. J. and Members of the EORTC Genito-Urinary Group.: Intravesical therapy with Adriamycin and 4-epirubicin for superficial bladder cancer. The experience of the EORTC Group. Cancer Chemother. Pharmacol, 30 (Suppl.), 595 (1982).
5. Herr, H. W., Laudone, V. P., Whitmore, W. F. Jr..: An overview of intravesical therapy for superficial bladder tumors. J. Urol., 138. 1363(1987).
6. Chai, M., Wientjes, M. G., Badalement, R. A., Burgers, J. K., Au, J.' L. S..: Pharmacokinetics of intravesical doxorubicin in superficial bladder cancer patients. J. Urol., 152. 374 (1994).
7. Lutzeyer, W., Rubben, H., Dahm, H..: Prognostic parameters in superficial bladder cancer.: An analysis of 315 cases. J. Urol. 127, 250 (1982).
8. Lundbeck, F., Pedersen, D., Stroyer, I., Uldall, A..: Absorption of doxorubicin hydrochloride during bladder washings in treatment of noninvasive bladder tumors. Urology, 18, 161 (1981).
9. Larson, A., Eksborg, S., Fritjoffson, A..: Intravesical instillation of adriamycin early after transurethral resection measurements of plasma levels. Eur. Urol., 10, 398 (1984).
10. Brantley, T., David, C..: Complications of intravesical chemotherapy. Urol. Clin. North Am.. 79,529(1992).
11. Melekos, M. D., Dauahauer, H., Fokaefs, E., Barbalias, G..: Intravesical instillations of 4-Epidoxorubicin (Epirubicin) in the prophylactic treatment of superficial bladder cancer.: Results of a controlled prospective study. J. Urol., 147. 371 (1992).
12. Fernando, C. S., Fernando, F., Teixeira, B., Almedia, S..: 4-Epidoxorubicin versus mitomycin C intravesical chemoprophylaxis of superficial bladder cancer. Eur. Ural.. 27,42(1992).
13. Burk, K., Kurt, K. H., Newling, D..: Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer. Prog. Clin. Biol. Res., 303. 423 (1989).
14. Whelan, P., Gumming, J. A., Garvie, W. H. H., Hargreave, T. B., Kirk, D., Newling, D. W. W., Robinson, M. R. G., Smith, P. H..: Multi-centre Phase II study of low dose intravesical epirubicin in the treatment of superficial bladder cancer. Br. J. Urol., 67. 600(1991).